المؤلفون: David G. Alleva, Eline A. Feitsma, Yester F. Janssen, Hendrikus H. Boersma, Thomas M. Lancaster, Thillainaygam Sathiyaseelan, Sylaja Murikipudi, Andrea R. Delpero, Melanie M. Scully, Ramya Ragupathy, Sravya Kotha, Jeffrey R. Haworth, Nishit J. Shah, Vidhya Rao, Shashikant Nagre, Shannon E. Ronca, Freedom M. Green, Stephen A. Shaw, Ari Aminetzah, Schelto Kruijff, Maarten Brom, Gooitzen M. van Dam, Todd C. Zion

المصدر: npj Vaccines, Vol 9, Iss 1, Pp 1-12 (2024)

مصطلحات موضوعية: Immunologic diseases. Allergy, RC581-607, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2059-0105

URL الوصول: https://doaj.org/article/3e169ceb8cc4445682f02ab1847c3f9e

المؤلفون: Andrea R Delpero, Larry Karnes, Shannon E. Ronca, Shashikant Nagre, David G. Alleva, Sarah S Webb, Hanne Andersen Elyard, Allison I Jasa, Thomas M. Lancaster, JoAnn Yee, Sylaja Murikipudi, Vidhya Rao, Frans Sollie, Nishit J Shah, Freedom M Green, Melanie M Scully, Jeffrey R Haworth, Thillainaygam Sathiyaseelan, Emma K Greaves, Ramya Ragupathy, Jeffrey Klein, Todd C. Zion

المصدر: Vaccine

مصطلحات موضوعية: medicine.medical_treatment, PFU, plaque-forming units, Antibodies, Viral, Immunoglobulin G, Neutralization, Mice, PRNT, plaque reduction neutralization test, Infectious disease, ID50, Inhibitory Dilution 50%, SP, Spike Protein, NHP, non-human primate, Immunogenicity, Titer, Infectious Diseases, Spike Glycoprotein, Coronavirus, Vaccines, Subunit, Molecular Medicine, APCs, antigen-presenting cells, Rabbits, EUA, Emergency Use Authorization, Adjuvant, Primates, COVID-19 Vaccines, Recombinant Fusion Proteins, Ag, antigen, MFI, mean fluorescent intensity, Biology, Article, Virus, nAb, neutralizing antibody, Neonatal Fc receptor, PRNT50, maximum dilution with greater than 50% inhibition, Antigen, ACE2, angiotensin converting enzyme-2, medicine, Animals, Fc-fusion, SP/RBD, spike protein receptor binding domain, Pandemic, General Veterinary, General Immunology and Microbiology, Prophylaxis, ELISA, Enzyme Linked Immunosorbent Assay, SARS-CoV-2, Public Health, Environmental and Occupational Health, COVID-19, Antibodies, Neutralizing, Virology, Coronavirus, HCS, Human convalescent serum, OD, optical density, P, passage, biology.protein

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fbd52d976e8f0e684d66cd171ccbc43
https://doi.org/10.1016/j.vaccine.2021.09.077

المؤلفون: Yester F. Janssen, Eline A. Feitsma, Hendrikus H. Boersma, David G. Alleva, Thomas M. Lancaster, Thillainaygam Sathiyaseelan, Sylaja Murikipudi, Andrea R. Delpero, Melanie M. Scully, Ramya Ragupathy, Sravya Kotha, Jeffrey R. Haworth, Nishit J. Shah, Vidhya Rao, Shashikant Nagre, Shannon E. Ronca, Freedom M. Green, Ari Aminetzah, Frans Sollie, Schelto Kruijff, Maarten Brom, Gooitzen M. van Dam, Todd C. Zion

المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS)

المصدر: Vaccine
Vaccine, 40(9), 1253-1260. ELSEVIER SCI LTD

مصطلحات موضوعية: Adult, History, COVID-19 Vaccines, Polymers and Plastics, Adolescent, HCS, human convalescent serum, Antibodies, Viral, Industrial and Manufacturing Engineering, Article, Young Adult, Clinical Trials, Phase II as Topic, Immunogenicity, Vaccine, ACE2, angiotensin converting enzyme-2, Humans, Business and International Management, Aged, Fc-fusion, SP/RBD, spike protein receptor binding domain, Infectious disease, SAE, serious adverse event, General Veterinary, General Immunology and Microbiology, Pandemic, SP, Spike Protein, Prophylaxis, SARS-CoV-2, ELISA, Enzyme Linked Immunosorbent Assay, Public Health, Environmental and Occupational Health, COVID-19, Middle Aged, AKS-452, Antibodies, Neutralizing, Coronavirus, Infectious Diseases, Immunoglobulin G, Spike Glycoprotein, Coronavirus, Vaccines, Subunit, Molecular Medicine, Vaccine, AE, adverse event

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::323329ba0f3a6ae40363118135c37a0a
http://europepmc.org/articles/PMC8802018